Use and indications of cholestyramine and bile acid sequestrants

被引:0
作者
Franco Scaldaferri
Marco Pizzoferrato
Francesca Romana Ponziani
Giovanni Gasbarrini
Antonio Gasbarrini
机构
[1] Catholic University of Rome,
[2] Fondazione Ricerca in Medicina ONLUS,undefined
来源
Internal and Emergency Medicine | 2013年 / 8卷
关键词
Cholestyramine; Bile acid sequestrants; Colestipol; Colesevelam;
D O I
暂无
中图分类号
学科分类号
摘要
Cholestyramine is a bile acid sequestrant, like colestipol and colesevelam. These molecules are positively charged non-digestible resins that bind to bile acids in the intestine to form an insoluble complex, which is excreted in the feces. They are used mainly for the treatment of primary hypercholesterolemia and hypercholesterolemia associated with mild hypertriglyceridemia, in patients not responding to dietary treatment as well as a second line-treatment for pruritus associated with cholestatic disease, in patients with incomplete biliary obstruction. Several data indicate that modulation of bile acid homeostasis has a good clinical effect in managing diabetes mellitus and the diarrhea from bile acid malabsorption. In this review, we present the “in label” use and indication for these compounds, revisiting the other clinical applications that may benefit from the use of bile acid sequestrants in the near future.
引用
收藏
页码:205 / 210
页数:5
相关论文
共 50 条
[21]   Long-term course in collagenous colitis and the impact of bile acid malabsorption and bile acid sequestrants on histopathology and clinical features [J].
Ung, KA ;
Kilander, A ;
Nilsson, O ;
Abrahamsson, H .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (06) :601-609
[22]   Bile Acid Sequestrants: Glucose-Lowering Mechanisms and Efficacy in Type 2 Diabetes [J].
Morten Hansen ;
David P. Sonne ;
Filip K. Knop .
Current Diabetes Reports, 2014, 14
[23]   CHOLESTEROL LOWERING AND BILE-ACID EXCRETION IN THE HAMSTER WITH CHOLESTYRAMINE TREATMENT [J].
SUCKLING, KE ;
BENSON, GM ;
BOND, B ;
GEE, A ;
GLEN, A ;
HAYNES, C ;
JACKSON, B .
ATHEROSCLEROSIS, 1991, 89 (2-3) :183-190
[24]   Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man [J].
Rust, C ;
Sauter, GH ;
Oswald, M ;
Büttner, J ;
Kullak-Ublick, GA ;
Paumgartner, G ;
Beuers, U .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2000, 30 (02) :135-139
[25]   Polymeric bile acid sequestrants: Review of design, in vitro binding activities, and hypocholesterolemic effects [J].
Hermankova, Eva ;
Zak, Aleg ;
Polakova, Lenka ;
Hobzova, Radka ;
Hromadka, Robert ;
Sirc, Jakub .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 144 :300-317
[26]   Surface-functionalized layered double hydroxide nanocontainers as bile acid sequestrants for lowering hyperlipidemia [J].
Lin, Chiao-Wen ;
Lin, Shi-Xiang ;
Kankala, Ranjith Kumar ;
Busa, Prabhakar ;
Deng, Jin-Pei ;
Lue, Sheng-I ;
Liu, Chen-Lun ;
Weng, Ching-Feng ;
Lee, Chia-Hung .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 590
[27]   Ammonium and guanidinium functionalized hydrogels-as bile acid sequestrants: Synthesis, characterization, and biological properties [J].
Huval, CC ;
Holmes-Farley, SR ;
Mandeville, WH ;
Petersen, JS ;
Sacchiero, RJ ;
Maloney, C ;
Dhal, PK .
JOURNAL OF MACROMOLECULAR SCIENCE-PURE AND APPLIED CHEMISTRY, 2004, A41 (03) :231-244
[28]   Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives [J].
Islam, Muhammad Shahidul ;
Sharif, Anjiya ;
Kwan, Nathania ;
Tam, Kam C. .
MOLECULAR PHARMACEUTICS, 2022, 19 (05) :1248-1272
[29]   Cholestyramine treatment in two dogs with presumptive bile acid diarrhoea: a case report [J].
L. Toresson ;
J. M. Steiner ;
J. S. Suchodolski .
Canine Medicine and Genetics, 8 (1)
[30]   Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials [J].
Hansen, Morten ;
Sonne, David P. ;
Mikkelsen, Kristian H. ;
Gluud, Lise Lotte ;
Vilsboll, Tina ;
Knop, Filip K. .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (05) :918-927